Ascendis Pharma A/S (ASND)
NASDAQ·Healthcare·Biotechnology
$230.67
-0.50%
Mkt Cap $14.73B
Analyst Ratings
No recent rating data.
Price Target (40 analysts)
$287.17
Range $250.00 – $342.00
Implied Upside
+24.5%
Consensus $287.17 vs current $230.67
NASDAQ·Healthcare·Biotechnology
$230.67
-0.50%
Mkt Cap $14.73B
No recent rating data.
Price Target (40 analysts)
$287.17
Range $250.00 – $342.00
+24.5%
Consensus $287.17 vs current $230.67